Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
LBPH
Company Announcements
Longboard Pharmaceuticals’ Phase 3 Study on LP352: A Potential Game-Changer for DEE Treatment
8d ago
LBPH
Premium
Company Announcements
Longboard Pharmaceuticals’ Promising Phase 3 Study on LP352 for Seizures in DEE
8d ago
LBPH
Premium
Company Announcements
Longboard Pharmaceuticals Advances in Dravet Syndrome Treatment with LP352 Study
8d ago
LBPH
Premium
Company Announcements
Longboard Pharmaceuticals Completes Acquisition and Delisting
8M ago
8K
LBPH
Premium
The Fly
Bright Minds Biosciences initiated with an Outperform at Baird
8M ago
DRUG
LBPH
Premium
Company Announcements
Longboard Pharmaceuticals Advances Neurological Treatments
8M ago
LBPH
Premium
The Fly
Longboard Pharmaceuticals reports Q3 EPS (63c), consensus (58c)
8M ago
LBPH
Premium
The Fly
Longboard Pharmaceuticals granted Orphan Drug Designation for bexicaserin
9M ago
LBPH
Premium
The Fly
Longboard Pharmaceuticals Inc options imply 0.8% move in share price post-earnings
9M ago
LBPH
Premium
The Fly
Largest borrow rate increases among liquid names
9M ago
LAC
SLS
Premium
The Fly
Largest borrow rate increases among liquid names
9M ago
NNE
SLI
Premium
The Fly
Longboard Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright
9M ago
LBPH
Premium
The Fly
Longboard Pharmaceuticals downgraded to Neutral from Buy at B. Riley
9M ago
GERN
LBPH
Premium
Company Announcements
Lundbeck Acquires Longboard Pharmaceuticals for $2.6 Billion
9M ago
8K
LBPH
Premium
The Fly
Truist downgrades Longboard to Hold on Lundbeck deal announcement
9M ago
LBPH
Premium
The Fly
Longboard Pharmaceuticals downgraded to Hold from Buy at Truist
9M ago
LBPH
Premium
The Fly
Longboard Pharmaceuticals downgraded to Neutral from Outperform at Baird
9M ago
LBPH
Premium
Market News
M&A News: Lundbeck to Acquire Longboard (NASDAQ:LBPH) for $2.6B
9M ago
LBPH
Premium
The Fly
Boeing to cut 10% of workforce, Lundbeck to acquire Longboard: Morning Buzz
9M ago
AS
BA
Premium
The Fly
Longboard Pharmaceuticals downgraded to Neutral from Outperform at Wedbush
9M ago
LBPH
Premium
The Fly
Longboard Pharmaceuticals deal comes earlier than expected, says Truist
9M ago
LBPH
Premium
The Fly
Longboard Pharmaceuticals downgraded to Neutral from Buy at B. Riley
9M ago
LBPH
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
